BAY1143269 is an orally effective mitogen-activated protein kinase-interacting serine/threonine-protein kinase 1 (MKNK1) inhibitor with potential anti-tumor activity.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted